Article
Prognostic factors in chronic myeloid leukaemia therapy
2012-01-01
Abstract excerpt
Chronic myeloid leukaemia (CML) is a chronic myeloproliferative disease that is characterized by the presence of the BCR-ABL1 protein, with subsequent increased tyrosine kinase activity. The Introduction of imatinib and second generation tyrosine kinase inhibitors revolutionized CML therapy; however, prognostic factors that can predict disease outcome are still measured using scores that have been developed during...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c7fd43b4-6305-52c9-b9ba-29b0eec4c388
- DOI
- 10.25560/9509